Q&K INTERNATIONAL GROUP-ADR (QK) Fundamental Analysis & Valuation

NASDAQ:QK • US74738J2015

Current stock price

2.74 USD
+0.03 (+1.11%)
Last:

This QK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. QK Profitability Analysis

1.1 Basic Checks

  • QK had negative earnings in the past year.
QK Yearly Net Income VS EBIT VS OCF VS FCFQK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 0 -500M -1B -1.5B

1.2 Ratios

Industry RankSector Rank
ROA -150.72%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QK Yearly ROA, ROE, ROICQK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 0 50 -50 -100 -150

1.3 Margins

Industry RankSector Rank
OM -16.4%
PM (TTM) -54.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QK Yearly Profit, Operating, Gross MarginsQK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. QK Health Analysis

2.1 Basic Checks

  • QK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • QK has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, QK has a worse debt to assets ratio.
QK Yearly Shares OutstandingQK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 200M 400M 600M 800M
QK Yearly Total Debt VS Total AssetsQK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

  • QK has an Altman-Z score of -23.54. This is a bad value and indicates that QK is not financially healthy and even has some risk of bankruptcy.
  • QK has a Debt/Equity ratio of -0.21. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.21
Debt/FCF N/A
Altman-Z -23.54
ROIC/WACCN/A
WACC5.7%
QK Yearly LT Debt VS Equity VS FCFQK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 -1B -2B

2.3 Liquidity

  • QK has a Current Ratio of 0.08. This is a bad value and indicates that QK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • QK has a Quick Ratio of 0.08. This is a bad value and indicates that QK is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
QK Yearly Current Assets VS Current LiabilitesQK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. QK Growth Analysis

3.1 Past

  • QK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.20%, which is quite impressive.
  • Looking at the last year, QK shows a very negative growth in Revenue. The Revenue has decreased by -14.22% in the last year.
  • QK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.66% yearly.
EPS 1Y (TTM)66.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.95%
Revenue 1Y (TTM)-14.22%
Revenue growth 3Y5.2%
Revenue growth 5Y18.66%
Sales Q2Q%-27.52%

3.2 Future

  • QK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.43% yearly.
  • The Revenue is expected to grow by 54.10% on average over the next years. This is a very strong growth
EPS Next Y98.3%
EPS Next 2Y40.48%
EPS Next 3Y25.43%
EPS Next 5YN/A
Revenue Next Year49.39%
Revenue Next 2Y52.34%
Revenue Next 3Y54.1%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QK Yearly Revenue VS EstimatesQK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
QK Yearly EPS VS EstimatesQK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. QK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for QK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QK Price Earnings VS Forward Price EarningsQK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -45.17
QK Per share dataQK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • QK's earnings are expected to grow with 25.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.48%
EPS Next 3Y25.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. QK Dividend Analysis

5.1 Amount

  • QK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

QK Fundamentals: All Metrics, Ratios and Statistics

Q&K INTERNATIONAL GROUP-ADR

NASDAQ:QK (9/23/2022, 8:23:17 PM)

2.74

+0.03 (+1.11%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)10-11
Inst Owners0.01%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap474.61M
Revenue(TTM)1.04B
Net Income(TTM)-569.17M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -45.17
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.84
BVpS-2.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -150.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -16.4%
PM (TTM) -54.93%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.74
Health
Industry RankSector Rank
Debt/Equity -0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -23.54
F-Score4
WACC5.7%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.95%
EPS Next Y98.3%
EPS Next 2Y40.48%
EPS Next 3Y25.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.22%
Revenue growth 3Y5.2%
Revenue growth 5Y18.66%
Sales Q2Q%-27.52%
Revenue Next Year49.39%
Revenue Next 2Y52.34%
Revenue Next 3Y54.1%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Q&K INTERNATIONAL GROUP-ADR / QK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Q&K INTERNATIONAL GROUP-ADR (QK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to QK.


What is the valuation status for QK stock?

ChartMill assigns a valuation rating of 0 / 10 to Q&K INTERNATIONAL GROUP-ADR (QK). This can be considered as Overvalued.


What is the profitability of QK stock?

Q&K INTERNATIONAL GROUP-ADR (QK) has a profitability rating of 1 / 10.


What is the financial health of Q&K INTERNATIONAL GROUP-ADR (QK) stock?

The financial health rating of Q&K INTERNATIONAL GROUP-ADR (QK) is 1 / 10.